Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM: Correspondence from The New England Journal of Medicine — Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

Comments

Popular posts from this blog

My current Facebook diatribe

» Dear Helen: From One American Lebanese Journalist To another… - Big Journalism